COVID-19-associated coagulopathy and acute kidney injury in critically ill patients

Bruno Caldin da Silva1, Ricardo Luiz Cordioli1, Bento Fortunato Cardoso Dos Santos1

  • 1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Einstein (Sao Paulo, Brazil)
|September 20, 2023
PubMed

Insights

Critically ill COVID-19 patients with acute kidney injury (AKI) had lower levels of natural anticoagulants, specifically antithrombin and protein C. These findings suggest a potential role for endogenous anticoagulants in AKI development in this population.

Area of Science:

  • Critical care medicine
  • Nephrology
  • Hematology

Background:

  • Thrombotic events and acute kidney injury (AKI) are prevalent complications in critically ill COVID-19 patients.
  • Understanding the underlying mechanisms, particularly coagulation abnormalities, is crucial for managing these patients.

Purpose of the Study:

  • To compare coagulation profiles in critically ill COVID-19 patients who developed AKI versus those who did not.
  • To investigate the role of endogenous anticoagulants in the development of AKI in this patient cohort.

Main Methods:

  • Coagulation tests, platelet function, fibrinolysis, and rotational thromboelastometry were performed on days 0, 1, 3, 7, and 14 post-ICU admission.
  • Patients were stratified into two groups: those who developed AKI and those who did not.

Main Results:

  • Patients with AKI were older and had lower baseline glomerular filtration rates.
  • While D-dimer, fibrinogen, and rotational thromboelastometry results were similar between groups, antithrombin activity and protein C levels were significantly lower in patients who developed AKI.
  • Lower protein C levels were observed consistently throughout the intensive care unit stay in the AKI group.

Conclusions:

  • Critically ill COVID-19 patients who developed AKI demonstrated reduced levels of endogenous anticoagulants.
  • Further research is warranted to elucidate the specific role of natural anticoagulants in the pathophysiology of AKI in critically ill COVID-19 patients.
Abstract

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
29
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
32